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Siamycin I disrupts growth and quorum sensing in Enterococcus faecalis. Using puriﬁed intact pro-
tein, we demonstrate here that quorummembrane sensor kinase FsrC is a direct target of siamycin I,
reducing pheromone-stimulated autophosphorylation activity by up to 91%. Inhibition was non-
competitive with ATP as substrate. Other ATP-binding enzymes were also inhibited, including nine
other membrane sensor kinases of E. faecalis, Rhodobacter sphaeroides PrrB, porcine Na+-dependent
ATPase and the catalytic subunit of bovine protein kinase A, but not bacterial b-galactosidase, con-
ﬁrming targeted inhibition of a wide range of ATP dependent reactions, and elucidating a likely
mechanism underlying the lethality of the inhibitor.
Structured summary of protein interactions:
PrrB phosphorylates PrrB by protein kinase assay (View interaction)
FsrC phosphorylates FsrC by protein kinase assay (View interaction)
Crown Copyright  2011 Published by Elsevier B.V. on behalf of Federation of European Biochemical
society. All rights reserved.1. Introduction bacterial death has remained unclear, but studies in E. faecalis haveSiamycin I is a 21-residue tricyclic peptide that is synthesised as
a secondary metabolite in actinomycetes [1]. It has the same struc-
ture as the previously reported inhibitor NP-06 [2] and the same
molecular mass as RP-71955 (in which two residues occupy
exchanged positions in the sequence) [3], and all three peptides
have been shown to possess anti-human immunodeﬁciency virus
(HIV) activity [2–4], with siamycin I shown to possess anti-
membrane fusion properties and to interact speciﬁcally with the
HIV envelope glycoprotein, gp160 [4]. Siamycin I and structurally
related siamycin II also exhibit strong antimicrobial activities
against Gram-positive bacteria including hospital-acquired infec-
tion agent Enterococcus faecalis [1,5]. The precise mechanism ofd by Elsevier B.V. on behalf of Fede
ting pheromone
e for Structural Molecular
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niversity of Leeds, Leeds LS2
.K. Phillips-Jones).
y Laboratory Macromolecular
e Biológica (ITQB-UNL), Av.so far revealed that siamycin I inhibits production of gelatinase and
gelatinase biosynthesis-activating pheromone (GBAP) at submi-
cromolar concentrations, and inhibits cell growth at above micro-
molar concentrations, suggesting multiple sites of inhibition [1].
Sublethal concentrations of siamycin I also attenuated bioﬁlm for-
mation, and the inhibitor was suggested to constitute a novel
means for treating enterococcal infections [1].
Gelatinase (GelE) is an important virulence factor in E. faecalis
[6,7]. It is involved in bioﬁlm formation and therefore adherence
of the pathogen [8], and is important for bioﬁlm development
[9], and pathogenicity in animal models [10–12]. Expression of
GelE and other virulence factors such as SprE is regulated by the
Fsr regulatory pathway, a quorum-sensing mechanism that is
dependent on cell density [7,8,13–15]. The 11-residue cyclic pep-
tide GBAP is the autoinducing peptide [16,17]. When extracellular
GBAP concentrations exceed 1 nM, the activity of the FsrCA
two-component system is increased [17]. Cyclised GBAP has been
synthesised chemically and shown to be active in vivo [18] and
in vitro [19]. Ma et al. (2008) conﬁrmed that FsrC is the sensor his-
tidine kinase (SK) that responds to GBAP using a puriﬁed intact
version of FsrC possessing its putative sensory and hydrophobic
transmembrane regions in in vitro autophosphorylation assaysration of European Biochemical society. All rights reserved.
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response regulator FsrA which in turn becomes phosphorylated
and activates transcription of gelE, sprE and other virulence genes
in a quorum-dependent fashion. The speciﬁc mechanisms by
which siamycin I inhibits both the viability of the bacterium and
its gelatinase and GBAP production remain unclear. It has been
suggested that siamycin I may interact with FsrC either directly
or more indirectly by integrating into the membrane, coinciden-
tally perturbing FsrC activity [1]. With the recent availability of
an intact, puriﬁed and active FsrC sensor protein for direct
in vitro studies [19], and therefore an opportunity for a direct ap-
proach using the full-length membrane sensor, the present study
was undertaken to establish the mechanisms of speciﬁcity and
lethality of the inhibitor, and in particular to establish whether
the target of siamycin I inhibition is FsrC itself, thereby accounting
for the observed inhibition of fsr quorum sensing functions by
siamycin I. Here we report that both GBAP-stimulated and non-
GBAP-stimulated FsrC activities are inhibited by siamycin I, and that
inhibition is non-competitive. Siamycin I also inhibited the
activities of all nine further intact membrane sensor kinases from
E. faecalis included in the study, and also a range of other ATP-
dependent enzymes of both prokaryotic and eukaryotic origin, but
not of ATP-independent b-galactosidase. Siamycin I therefore inhib-
its a wide range of ATP-dependent enzymes, presumably account-
ing for the lethality of siamycin I towards bacterial cells observed
through measurements of minimal inhibitory concentrations of
the inhibitor reported previously [1,5], and in the present study.
2. Materials and methods
2.1. Bacterial strains and plasmids, reagents and chemicals
The original E. faecalis V583 source strain of the fsrC gene, the
Escherichia coli overexpression strain BL21 [DE3] and the fsrC over-
expression plasmid pTTQHK15 used for the production of puriﬁed
intact FsrC have been described previously [19]. [c-32P]ATP and
[c-33P]ATP (3000 Ci/mmol) were obtained from Perkin Elmer, UK.
Dodecyl-N-maltoside (DDM) was obtained from Melford Biosci-
ences. Agarose-immobilised Ni2+-nitrilotriacetic acid (NTA) resin
was obtained from Qiagen. Sources and use of gelatinase-biosyn-
thesis activating pheromone and siamycin I have been described
previously [1,19]; stock solutions of 77 lM or 0.5 mM GBAP (dis-
solved in 3.1 or 20% acetonitrile, respectively) and of 4.6 mM
(and two-fold serial dilutions thereof in water) siamycin I (dis-
solved in 100% methanol) were prepared. The cyclic atrial natri-
uretic peptide (ANP) from rat, the catalytic subunit of bovine
heart protein kinase A, b-galactosidase and the Na+-dependent
ATPase from porcine cerebral cortex were all purchased from Sig-
ma–Aldrich (UK). All media, stock buffers and procedures for
growth of bacterial cultures followed previous methods [20]. All
other chemicals and reagents employed were of Analar or equiva-
lent grade unless otherwise stated.
2.2. Determinations of minimal inhibitory concentrations (MICs)
MICsweredeterminedusingwell establishedmethodsdescribed
previously [21]. Brain heart infusionbrothwasused to culture E. fae-
calis strains. For GBAP experiments, GBAP (prepared in 1.2% acetoni-
trile)wasadded toaﬁnal concentrationof100 nM;controls received
addition of the equivalent volumes of acetonitrile.
2.3. Puriﬁcation of FsrC protein
Protocols have been described previously for the overexpres-
sion and puriﬁcation of intact recombinant FsrC-(His6) usingE. coli BL21 [DE3]/pTTQHK15 [19]. Solubilisation of the protein
from inner membranes of the expression host was achieved using
1% DDM and all buffers for subsequent nickel afﬁnity puriﬁcation
and protein storage contained 0.025% DDM to maintain protein
solubility.
2.4. In vitro autophosphorylation assays
Autophosphorylation assays for all the intact puriﬁed mem-
brane histidine sensor kinases (80 pmol) and for bovine heart pro-
tein kinase A (36.7 pmol) were performed as described previously
in the absence of added DDM [19,22]. Siamycin I (100 lM) was
preincubated with protein for 20 min at 22 C prior to the initia-
tion of the phosphorylation assays using 3.75 lCi [c-32P]- or
[c-33P]-ATP at a concentration of 50 lM for 30 min. Reactions
were then terminated by addition of 5 ll 4 SDS–PAGE sample
loading buffer as described previously [19,22]. Siamycin I titration
assays using FsrC were performed in the presence or absence of a
two-fold molar excess of GBAP and in the presence or absence of
increasing concentrations of up to a 10-fold molar excess
(100 lM) siamycin I. All samples were prepared for SDS–PAGE
analysis as described previously [19,22]. Phosphorylated proteins
were visualised by autoradiography using BioMax ﬁlm (Kodak) ex-
posed for 1–7 days and quantitated using a Fuji BAS 1000 phos-
pho-imaging analyzer system (Fujiﬁlm Co., Japan) with AIDA 2D
analytical software (Raytest) [19] or by densitometry (Biorad
Laboratories).
Time course experiments employed 800 pmol puriﬁed FsrC
preincubated in reaction buffer for 20 min in the presence and
absence of two-fold molar excess of GBAP (10.7 lM) and/or a
10-fold molar excess of siamycin I (50 lM), followed by initiation
of reactions using 37.5 lCi [c-32P]ATP at a ﬁnal concentration of
50 lM, in a total reaction volume of 150 ll. Samples (15 ll) were
removed at time intervals between 0 and 60 min and reactions
terminated by addition of 5 ll 4 SDS–PAGE sample loading buffer
as described above and in Refs. [19,22].
2.5. Kinetic studies
Autophosphorylation assays were performed as described
above except that a range of concentrations of ATP substrate up
to 300 lM were used in the presence and absence of 200 lM sia-
mycin I. Initial velocities were measured as FsrC-P levels after
20 min incubation at room temperature [19].
The following models were used to analyse and compare the
initial rate data using GraphPad Prism 5. Competitive inhibition:
KobsM ¼ KMð1þ ½I=K iÞ, Y ¼ VmaxX=ðKobsM þ XÞ; non-competitive
inhibition: V inhmax ¼ Vmax=ð1þ I=K iÞ, Y ¼ V inhmaxX=ðKM þ XÞ; uncompet-
itive inhibition: Vappmax ¼ Vmax=ð1þ I=aK iÞ, KappM ¼ KM=ð1þ I=aK iÞ,
Y ¼ Vappmax XðKappM þ XÞ; and mixed model: Vappmax ¼ Vmax=
ð1þ I=ðaK iÞÞ , KappM ¼ KMð1þ I=K iÞ=ð1þ I=ðaK iÞÞ, Y ¼ Vappmax X=
ðKappM þ XÞ.
2.6. ATPase assays
To determine whether siamycin I exerted any effect on the
activity of the Na+-dependent ATPase from porcine cerebral cortex,
a colorimetric assay of released inorganic phosphate employing
0.5 U/ml (0.3 U/mg) puriﬁed enzyme was used as described previ-
ously [23,24], in the presence and absence of 100 lM siamycin or
1.3 mM control inhibitor ouabain. All assays (including controls
and blanks) were performed in the presence of a ﬁnal concentra-
tion of 2% methanol, since siamycin I stock solutions were dis-
solved in 25% methanol. The assays contained no detergent
additions.
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b-Galactosidase activities in the presence and absence of
100 lM siamycin I were determined by measurements of the rates
of change in absorbance at 420 nm in the presence of o-nitro-
phenyl galactoside as substrate, using the method described previ-
ously [25]. Reactions (400 ll) typically employed 0.847 lg
(7.5 pmol) puriﬁed enzyme and linear rates over the ﬁrst 5 min
of the assay were used in the calculations. All reactions contained
2% ﬁnal concentration of methanol.Fig. 1. Inhibition of FsrC autophosphorylation by siamycin I. Puriﬁed intact FsrC
was overexpressed in E. coli BL21 [DE3] and puriﬁed as described previously [19].
(A) Reactions (15 ll) containing 80 pmol puriﬁed FsrC were preincubated at 24 C in
the presence or absence of a two-fold molar excess of GBAP (10.7 lM) and in the
presence or absence of different concentrations of siamycin I. Autophosphorylation
reactions were undertaken for 30 min as described in [19] and Section 2. (B) Time
course of FsrC autophosphorylation in the presence and absence of a two-fold molar
excess of GBAP and/or a 10-fold molar excess of siamycin I. Reactions (150 ll)
containing 800 pmol puriﬁed FsrC were preincubated in the presence or absence of
GBAP (10.7 lM) and/or siamycin I (50 lM), followed by initiation of autophospho-
rylation reactions. Phosphorylated FsrC was visualised by autoradiography. Values
represent the mean ± standard deviation of triplicate determinations. Graphical
representation of phosphorimager data expressed as % pixel counts.3. Results and discussion
To determine whether FsrC is a target for siamycin I inhibition,
activity assays of FsrC autophosphorylation were undertaken in the
presence and absence of a two-fold molar excess of GBAP and a
range of siamycin I concentrations. Two-fold GBAP was employed
here since we demonstrated previously that this concentration
elicits an approx 10-fold increase in phosphorylated FsrC which
is maximal after 30 min in these assays [19], and that the kinetics
of autophosphorylation are similar in both the presence and
absence of GBAP (data not shown). The results are shown in
Fig. 1A. GBAP-stimulated activity of FsrC was not inhibited in the
presence of less than a 2.5:1 ratio of siamycin I:FsrC (or 5:1 molar
ratio of siamycin I:dimeric FsrC). However, when the ratio was
greater than 2.5:1, inhibition of activity measured by a marked
reduction in FsrC phosphorylation was observed, ranging from an
inhibition of 29% using 5:1 siamycin I:FsrC, 76% using 10-fold sia-
mycin and 91% using 20-fold (100 lM) siamycin I (Fig. 1A). These
data indicate that siamycin I exerts a direct inhibitory effect on
the FsrC protein of the Fsr pathway. The observed inhibition ap-
pears to be speciﬁc to siamycin I, since substitution of siamcyin I
with rat atrial natriuretic peptide (ANP), a cyclic peptide of similar
mass and residue number to siamycin I (28 residues and molecular
mass of 3062) into the autophosphorylation assays, resulted in no
observable inhibition (data not shown). We therefore conclude
that siamycin I inhibition of FsrC activity is a speciﬁc characteristic
of this particular cyclic peptide.
Time course experiments of FsrC autophosphorylation were
then undertaken to determine whether siamycin I inhibits both
GBAP-stimulated and intrinsic autophosphorylation of FsrC in the
absence of the activating pheromone. Autophosphorylation assays
were performed in triplicate over a 60 min period. Reactions
(150 ll) containing 800 pmol puriﬁed FsrC were prepared and pre-
incubated in the presence and absence of a two-fold molar excess
of GBAP (10.7 lM) and/or a 10-fold molar excess of siamycin I
(50 lM). Samples (15 ll) were removed at time intervals and reac-
tions terminated for analysis. The results are shown in Fig. 1B. The
presence of 10.7 lM GBAP produced an approximately seven-fold
increase in FsrC-P levels after 60 min compared to the control
assays containing FsrC alone. The presence of 50 lM siamycin I
in addition to 10.7 lM GBAP in the assays reduced the levels of
phosphorylated FsrC by approximately 50% (Fig. 1B). An even
greater level of inhibition of non-GBAP stimulated FsrC activity
(in the absence of added GBAP) by siamycin I was obtained numer-
ically (Fig. 1B), though this does not appear to be statistically
signiﬁcant presumably because of the relatively low levels of
FsrC-P that are produced throughout these conditions. We there-
fore conclude from these data that siamycin I is a signiﬁcant and
direct inhibitor of the GBAP-stimulated activity of FsrC, and there-
fore that this inhibition accounts for at least part of the inhibition
of the Fsr pathway activity and gelatinase production characterised
previously [1,26].
The inhibition of FsrC was characterized in more detail. Inhibi-
tion using 200 lM siamycin I was measured using a range of ATPsubstrate concentrations to study the kinetic mechanism of inhibi-
tion. Under the assay conditions employed here, initial velocities
are obtained [19] and Michaelis–Menten kinetics apply to such
protein kinases. The data were ﬁtted to equations for competitive,
non-competitive, uncompetitive and mixed models of inhibition
by non-linear regression analysis of the reaction velocities. The
R2 values obtained in each case were similar (mixed model,
0.8793–0.9351; non-competitive, 0.8776–0.8653; uncompetitive,
0.8792–0.9302; and competitive, 0.8787–0.7621). Fig 2A shows
Fig. 3. Inhibition by siamycin I of a collection of different ATP-dependent enzymes.
(A), (B), and (C) Inhibition of puriﬁed FsrC (EF1820) and nine other intact membrane
sensor kinases from E. faecalis V583. Proteins were prepared as described previously
[19]. Reactions (15 ll) containing 80 pmol puriﬁed protein were preincubated for
20 min at 24 C in the presence or absence of a 20-fold molar excess of siamycin I
(100 lM) (and in the case of FsrC, also in the presence and absence of a two-fold
molar excess of its activating signal GBAP (10.7 lM)), followed by initiation of
autophosphorylation reactions. The amount of radiolabel associated with each
protein band was quantiﬁed as described previously [19]. –, Protein alone; +G,
protein in the presence of GBAP; +S, protein in the presence of siamycin I; and +GS,
protein in the presence of GBAP and siamycin I. Values shown below each gel
denote % activity compared with relevant control (100%). (D) The effect of siamycin
I on the activities of other enzyme activities. Activities were assayed in the presence
and absence of 100 lM siamycin. The molecular weight for porcine ATPase (alpha
and beta subunits) was derived from nucleotide sequence data and was taken to be
148839 Da (http://www.expasy.org). All data were derived from triplicate data and
the standard deviation values are shown.
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Lineweaver–Burke plot (Fig 2B) clearly demonstrates non-
competitive inhibition (and a calculated KM of 487 lM).
Since non-competitive inhibition implies reversible siamycin I
binding to both the FsrC–ATP complex as well as to FsrC (possibly
with different afﬁnities, as indicated by the mixed model inhibition
ﬁts), the speciﬁcity and lethality of the inhibitor towards other
ATP-binding enzymes were then investigated. Firstly, its effects
on a range of other membrane sensor kinases from E. faecalis
V583 were investigated, including the VicK (EF1194) sensor kinase
which is a component of the VicKR two-component system that is
essential for viability in E. faecalis [27,28]. The inhibition of bacte-
rial growth by siamycin I is well documented for several species of
Gram-positive bacteria [5] including E. faecalis OG1RF [1]. Since our
investigation concerns the effect of the inhibitor towards several
membrane sensor kinases originating from the V583 strain of E.
faecalis, the sensitivity of this strain towards siamycin I was ﬁrstly
established through MIC determinations; in the presence or
absence of 100 nM GBAP, the MIC was conﬁrmed to be 5 lg ml1,
which is in good agreement with the 2–11 lg ml1 (1–5 lM) val-
ues previously reported for strain OG1RF [1]. In addition to intact
FsrC (EF1820) and VicK (EF1194), puriﬁed preparations of a further
eight intact membrane sensors originating from E. faecalis V583
were all prepared as described previously [19]. Autophosphoryla-
tion assays using 80 pmol of each protein in the presence and
absence of 100 lM (20-fold excess) siamycin I were performed
and the results are shown in Fig. 3A–C. In common with FsrC
(EF1820) (both in the presence or absence of GBAP), all of these
membrane sensors exhibited reduced levels of phosphorylated
protein (and therefore activity) in the presence of siamycin I
(Fig. 3A–C). Interestingly, siamycin I exerted a wide variation in
levels of inhibition. EF3197 exhibited the most sensitivity to
siamycin I, with levels of phosphorylation reduced to 8% of those
in the absence of the inhibitor, whilst the protein least affected
was EF0927 which retained 69% of its activity in the presence of
siamycin I. Whilst it is the sensory domains of these proteins that
are least homologous (to be expected because each is for sensing
different signalling ligands), these proteins all share the ability to
bind and hydrolyse ATP. Presumably this shared similarity is the
common basis for binding and inhibition by siamycin I, especially
given the identiﬁed non-competitive inhibition of the FsrC–ATP
complex (Fig. 2). To investigate this further, a wider range of pro-
tein types that possess or do not possess the ability to bind and
hydrolyse ATP were included in the study (Fig. 3D). The activity
of each puriﬁed protein described below was assayed in the pres-
ence and absence of 100 lM siamycin I.
To determine whether siamycin I inhibits the activities of mem-
brane sensor kinases originating from Gram-negative species,Fig. 2. Kinetics of siamycin I inhibition. Autophosphorylation assays of FsrC were perfor
and absence of 200 lM siamycin I. (A) Plot of FsrC-P levels measured in radioactivity pixe
used in the assays. () Solid line – control; (j), solid line – in the presence of 200 lM sia
inhibition, following analysis and comparisons of mixed, uncompetitive, non-competitiv
Burke plot of data in (A). Measurements were in triplicate and standard error values areintact PrrB (RegB) of Rhodobacter sphaeroides was puriﬁed as de-
scribed previously [22]. Previous studies already established that
it can be puriﬁed as an intact and active protein and that it remains
responsive to its signalling ligand in in vitro autophosphorylation
assays [29]. Use of 80 pmol (5.3 lM) PrrB in autophosphorylation
assays in the presence of 100 lM siamycin I resulted in a signiﬁ-
cant reduction in levels of PrrB-P (Fig. 3D), conﬁrming that siamy-
cin I signiﬁcantly inhibits PrrB autophosphorylation activity. It ismed as described in Section 2 using different concentrations of ATP in the presence
ls (initial velocity, V) after 20 min assay time versus concentration of ATP substrate
mycin I. Curved lines with no symbols depict curves of best ﬁt for non-competitive
e and competitive models using GraphPad Prism 5 (see Section 2). (B) Lineweaver–
shown by the error bars.
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nases from a range of different bacteria, including Gram-negative
species. If so, the general lack of growth inhibition exhibited by
Gram-negative species in response to siamycins reported previ-
ously [5] is presumably attributable to accessibility of the inhibitor
to its target sites, suggesting impermeability of the inhibitor across
the Gram-negative outer membrane as is the case for the majority
of bacteriocins produced by Gram-positive bacteria, e.g. nisin.
The effect of siamycin I on ATPase was investigated, since in
common with membrane sensor kinases, there is a dependence
on ATP binding and hydrolysis. Fig 3D shows that the activity of
a puriﬁed membrane Na+-dependent ATPase, assayed through
measurements of inorganic phosphate liberated upon ATP hydroly-
sis, exhibited a signiﬁcant inhibition by siamycin I. Likewise, the
activity of another ATP-dependent enzyme, the soluble catalytic
subunit of a bovine protein kinase, measured by incorporation of
radiolabel following addition of labelled ATP into phosphorylation
assays, was also signiﬁcantly inhibited, though to a lesser extent
(Fig. 3D). When the activity of unrelated puriﬁed b-galactosidase
of E. coli was assayed using o-nitrophenyl galactoside as substrate,
no effect of the inhibitor was observed on enzyme activity
(Fig. 3D). b-Galactosidase activity relies on the formation of tetra-
mers; presumably the mechanism of siamycin I inhibition ob-
served here is not by means of disruption or inhibition of
formation of the active tetramers. By extrapolation, this ﬁnding
may suggest that the mechanism by which siamycin I inhibits sen-
sor kinases is not via disruption of the oligomerisation (dimerisa-
tion) events required for transphosphorylation activity.
These results conﬁrm that siamycin I exhibits speciﬁc and direct
inhibition of the membrane sensor kinase FsrC, conﬁrming at least
one target in the Fsr pathway previously implicated in the siamy-
cin I-mediated inhibition of gelatinase and GBAP production [1].
However, it is clear from the present study that siamycin I is likely
to inhibit the activities of a range of different enzymes, including
membrane sensor kinases, protein kinases and ATPases involved
in ATP-dependent reactions in a wide range of organisms, presum-
ably gaining access to its target sites across the membrane(s) and
exerting inhibitory effects on downstream cell processes thereby
providing an explanation for the mechanisms by which bacterial
growth is inhibited by siamycin I.
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